Bayer and PCF launch darolutamide challenge awards for prostate cancer
The two projects will be awarded $1m each to support their clinical investigations
Read More
Tag: Prostate Cancer Foundation
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
